Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Amerikaanse aandelen Terug naar discussie overzicht

Sunhydrogen (vh Hypersolar)

461 Posts
Pagina: «« 1 ... 18 19 20 21 22 ... 24 »» | Laatste | Omlaag ↓
  1. forum rang 9 nine_inch_nerd 29 januari 2022 13:21
    1. An amendment to our articles of incorporation to increase our authorized shares of common stock from 5,000,000,000 to 10,000,000,000.

    2. An amendment to our articles of incorporation to effect a reverse stock split of our common stock by a ratio of not less than 1-for-100 and not more than 1-for-500 at any time prior to the one year anniversary of filing the definitive information statement with respect to the reverse split, with the Board of Directors having the discretion as to whether or not the reverse split is to be effected, and with the exact ratio of any reverse split to be set at a whole number within the above range as determined by the Board in its discretion.

    3. The adoption of the SunHydrogen. Inc. 2022 Equity Incentive Plan.

    The action will become effective on the 20th day after the definitive information statement is mailed to our stockholders.
    The enclosed information statement contains information pertaining to the matters acted upon.
  2. [verwijderd] 31 januari 2022 13:29
    Ik ben ook enigzins sceptisch. Aan de ene kant goed dat ze naar de grote markt willen, maar jammer dat het zo moet.
    Maar ze hebben wel gezegd in 2022 in productie te willen gaan toch? Dus misschien behouden ze positief nieuws tot de reverse split of kinkt dat gek?
  3. forum rang 9 nine_inch_nerd 31 januari 2022 13:48
    quote:

    Raneman schreef op 31 januari 2022 13:29:

    Ik ben ook enigzins sceptisch. Aan de ene kant goed dat ze naar de grote markt willen, maar jammer dat het zo moet.
    Maar ze hebben wel gezegd in 2022 in productie te willen gaan toch? Dus misschien behouden ze positief nieuws tot de reverse split of kinkt dat gek?
    Als ze een stap willen maken naar Nasdaq/NYSE, dan moeten ze toch wel iets te bieden hebben: een plan, een visie, een product dat op grote schaal werkt en rendabel is en eventueel al klanten.
    Anders heeft een opwaardering geen zin en zal na de reverse het aandeel kelderen.

    Dus ik verwacht (hoop op) nieuws vwb commercialisering met parallel een reverse voor een intrede NYSE/Nasdaq.

    Overname wordt ook gespeculeerd...
  4. Radikal 1 februari 2022 13:03
    SunHydrogen Expands Industrial Partnerships in Scale-Up Process for its Nanoparticle-Based Green Hydrogen Technology

    SANTA BARBARA, CA – February 1, 2022 – SunHydrogen, Inc. (OTC:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today provided an update on the progress and strategy of the scale-up process for its nanoparticle-based green hydrogen technology.

    In February of 2021, SunHydrogen announced its partnership with SCHMID Group of Freudenstadt, Germany to design and define a process platform that enables mass manufacturing of SunHydrogen's nanoparticle-based green hydrogen panels. The partnership initially focused on three key development stages: design evaluation, process evaluation and system engineering.

    Through the collaboration, SunHydrogen and SCHMID identified key manufacturing needs in the areas of electroplating chemistries, substrate processing and membrane and catalyst integration that require collaboration with specialized industry partners.

    SunHydrogen is pleased to share that its partnership with SCHMID Group will continue in 2022 with a narrowed focus.

    SCHMID will focus its efforts on the design and engineering of SunHydrogen's panel housing, a crucial system element that ensures safe and efficient hydrogen collection. Concurrently, SunHydrogen will seek to diversify its commercialization strategy by forming relationships with industrial partners specialized in individual manufacturing components such as electroplating, substrate processing and catalyst/membrane integration.

    At this time, SunHydrogen will continue its ongoing work with development partners InRedox and MSC Co. LTD in the areas of substrate manufacturing and electroplating chemistries, respectively. The company has also found a new partner in Geomatec, a high-performance thin-film manufacturer based in Japan, who will work alongside InRedox to facilitate SunHydrogen’s transition to large-scale substrate manufacturing.

    "Our partnership with SCHMID has allowed us to determine that our scale-up process can benefit from a diversified approach," said SunHydrogen CEO Tim Young. "We look forward to continuing to work with SCHMID to develop our panel housing, while also continuing to engage new industrial partners and move toward commercialization as efficiently as possible."

    About SunHydrogen, Inc.
  5. forum rang 9 nine_inch_nerd 1 februari 2022 13:24
    Yep! Wordt vervolgd...

    quote:

    Radikal schreef op 1 februari 2022 13:03:

    SunHydrogen Expands Industrial Partnerships in Scale-Up Process for its Nanoparticle-Based Green Hydrogen Technology
    .......
    At this time, SunHydrogen will continue its ongoing work with development partners InRedox and MSC Co. LTD in the areas of substrate manufacturing and electroplating chemistries, respectively. The company has also found a new partner in Geomatec, a high-performance thin-film manufacturer based in Japan, who will work alongside InRedox to facilitate SunHydrogen’s transition to large-scale substrate manufacturing.

    "Our partnership with SCHMID has allowed us to determine that our scale-up process can benefit from a diversified approach," said SunHydrogen CEO Tim Young. "We look forward to continuing to work with SCHMID to develop our panel housing, while also continuing to engage new industrial partners and move toward commercialization as efficiently as possible."

    About SunHydrogen, Inc.[/i]
    www.geomatec.com
  6. Johan8 1 februari 2022 13:54
    een samenwerking in Japan klinkt ook wat beter
    dan weer in China

    ze zijn goed bezig
  7. Radikal 1 februari 2022 14:00
    Ik heb ze al enkele jaren in portefeuille en hoop dat 2022 - 2023 de jaren van de waarheid gaan worden.
    fingers crossed :-)
  8. Klein Gevaarlijk Afval 28 maart 2022 12:51
    SANTA BARBARA, CA – March 28, 2022 – SunHydrogen, Inc. (OTC:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today provided an update to its shareholders from its Chief Scientific Officer, Dr. Syed Mubeen, on the company’s progress toward multiple planned 2022 milestones as follows.

    Over the past six months, we have expanded our industrial partnerships across the U.S., Germany, South Korea and Japan, and we have renewed and initiated new collaborations with the University of Iowa and the University of Michigan, respectively.

    Since assuming the role of Chief Scientific Officer, I have worked to expand SunHydrogen’s scientific operations and research capabilities to scale our nanoparticle technology. Today, I am proud to say that SunHydrogen is on track to demonstrate a production-quality prototype of its nanoparticle-based green hydrogen technology.

    SunHydrogen started 2022 with the addition of a new research and development laboratory in Coralville, Iowa, to fuel its goal of scaling up fabrication of its nanoparticle hydrogen generator units by the end of the 2022 fiscal year. We hired several new senior engineers and chemists and are in the process of streamlining manufacturing operations, a task made more accessible by increasing our personnel.

    SunHydrogen is also excited to report positive interim product development progress for the months of January and February. We have successfully validated the manufacturability of our growth substrates and deposition recipes at scales needed for production-quality prototype demonstration.

    We are currently trying to resolve supply chain challenges with some of our feedstocks and anticipate full resolution by early May. We are also finalizing research partnerships with external membrane and catalyst developers to integrate these elements into the architecture of our nanoparticle-based hydrogen generator units.

    SunHydrogen’s sponsored research agreements with the University of Iowa and the University of Michigan are ongoing, with the potential for additional research and product development milestones during the second half of 2022.

    Our plan for the remainder of 2022 is to build on this progress with multiple production-quality prototype demonstrations by the end of the year.

    Expected product development milestones we have set for Q4 2022 include:

    Successful fabrication of semiconductor units at production-quality prototype scales

    Successful integration of membranes at production-quality prototype scales

    Successful integration of catalysts at production-quality prototype scales

    Successful testing and demonstration of production-quality prototype units

    On behalf of the SunHydrogen team, we thank you for your support and we look forward to sharing our progress with you as we meet additional 2022 milestones.
  9. Radikal 28 maart 2022 13:17
    quote:

    klein gevaarlijk afval schreef op 28 maart 2022 12:51:

    SANTA BARBARA, CA – March 28, 2022 – SunHydrogen, Inc. (OTC:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today provided an update to its shareholders from its Chief Scientific Officer, Dr. Syed Mubeen, on the company’s progress toward multiple planned 2022 milestones as follows.

    Over the past six months, we have expanded our industrial partnerships across the U.S., Germany, South Korea and Japan, and we have renewed and initiated new collaborations with the University of Iowa and the University of Michigan, respectively.

    Since assuming the role of Chief Scientific Officer, I have worked to expand SunHydrogen’s scientific operations and research capabilities to scale our nanoparticle technology. Today, I am proud to say that SunHydrogen is on track to demonstrate a production-quality prototype of its nanoparticle-based green hydrogen technology.

    SunHydrogen started 2022 with the addition of a new research and development laboratory in Coralville, Iowa, to fuel its goal of scaling up fabrication of its nanoparticle hydrogen generator units by the end of the 2022 fiscal year. We hired several new senior engineers and chemists and are in the process of streamlining manufacturing operations, a task made more accessible by increasing our personnel.

    SunHydrogen is also excited to report positive interim product development progress for the months of January and February. We have successfully validated the manufacturability of our growth substrates and deposition recipes at scales needed for production-quality prototype demonstration.

    We are currently trying to resolve supply chain challenges with some of our feedstocks and anticipate full resolution by early May. We are also finalizing research partnerships with external membrane and catalyst developers to integrate these elements into the architecture of our nanoparticle-based hydrogen generator units.

    SunHydrogen’s sponsored research agreements with the University of Iowa and the University of Michigan are ongoing, with the potential for additional research and product development milestones during the second half of 2022.

    Our plan for the remainder of 2022 is to build on this progress with multiple production-quality prototype demonstrations by the end of the year.

    Expected product development milestones we have set for Q4 2022 include:

    Successful fabrication of semiconductor units at production-quality prototype scales

    Successful integration of membranes at production-quality prototype scales

    Successful integration of catalysts at production-quality prototype scales

    Successful testing and demonstration of production-quality prototype units

    On behalf of the SunHydrogen team, we thank you for your support and we look forward to sharing our progress with you as we meet additional 2022 milestones.
    En dat is nu eens het nieuws waar we zitten op te wachten zie.
    Ik wens iedere die aandelen van SunHydrogen heeft veel succes en mooie groene tijden tegemoet :-)
  10. Radikal 10 mei 2022 13:19
    SunHydrogen Engages Elite Scientist Dr. Arthur J. Nozik as Scientific Adviser

    SANTA BARBARA, CA – May 10, 2022 – SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today announced the appointment of Dr. Arthur J. Nozik, a distinguished leader in photoelectrochemistry, semiconductor nanoscience and additional closely related fields, as Scientific Adviser to the company.

    A Senior Research Fellow Emeritus of the National Renewable Energy Laboratory (NREL) and a Research Professor in the Department of Chemistry at the University of Colorado, Boulder, Dr. Nozik will work directly with Chief Scientific Officer Dr. Syed Mubeen and Director of Technology Dr. Joun Lee to evaluate SunHydrogen’s overall strategy and technique as the company works toward commercializing its nanoparticle-based green hydrogen technology.

    Dr. Nozik earned his B.S. in Chemical Engineering from Cornell University in 1959 and his Ph.D. in Physical Chemistry from Yale University in 1967.

    Through his career at NREL (formerly the Solar Energy Research Institute), he has established himself as a leader in the fields of photoelectrochemistry, semiconductor-molecule interfaces, quantum size effects, hot electron relaxation dynamics and multiple exciton generation in semiconductor quantum wells, quantum dots, quantum wires and nanostructures, and applications of this science to improve solar photon conversion technologies.

    Prior to NREL, Dr. Nozik held research positions at the Allied Chemical Corporation and the American Cyanamid Company, where efforts were focused on bringing emerging technologies and solutions to commercialization.

    “From the start of my career, I have been extremely interested in and focused on exactly what SunHydrogen is doing,” said Dr. Nozik. “I’m hopeful that I can contribute to SunHydrogen’s success in bringing this unique solution to the market.”

    Dr. Nozik has published over 270 peer-reviewed papers, proceedings, books and book chapters. He has been cited over 47,000 times, presented over 380 invited talks and has been awarded 11 U.S. patents and numerous honors for his work.

    Additionally, Dr. Nozik serves as a bi-annual consultant for Samsung, evaluating proposals from external scientists in the fields of solar energy, quantum-computing, electronics and more to determine if they are scientifically sound and suitable for integration with Samsung.

    “Dr. Nozik brings an immense wealth of knowledge to our team,” said SunHydrogen CEO Tim Young. “It will be extremely valuable for him to not only evaluate our current methodology, but also bring new insights, strategies and solutions to our scientists. We are grateful for the opportunity to work with someone who has been at the cutting edge of this field since the start.”
  11. forum rang 9 nine_inch_nerd 10 mei 2022 13:41
    Weer een slimme man erbij.
    Ik ben twee weken geleden eruit gestapt en verlies genomen. Resterend bedrag helemaal in Sayona Mining geduwd en hoop iets van mijn verlies te compenseren. Of ik ooit nog zolang HYSR een OTC-er is kan instappen, weet ik niet. Ik heb mijn account bij Saxo (voorheen BinckBank) opgezegd ivm hoge kosten daar. Ga alles via DeGiro handelen. Flatex heb ik ook nog, maar die gaan ook in Nederland stoppen en mijn portefeuille wordt tzt overgeheveld naar DeGiro. En volgens mij doet DeGiro niet aan OTC's.
    Dan maar wachten op een reverse-split, waarna ze tzt naar de Nasdaq kunnen en bereikbaar zijn voor meerdere brokers waaronder DeGiro.
    Blijf HYSR wel volgen, natuurlijk.
  12. Radikal 28 juni 2022 12:47
    SunHydrogen Shares Q2 Update on Progress Toward 2022 Milestones for Commercialization of its Nanoparticle-Based Green Hydrogen Technology

    SANTA BARBARA, CA – June 28, 2022 – SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today provided a Q2 update on the company’s progress toward multiple planned 2022 milestones.

    On March 28, SunHydrogen shared a Q1 update detailing the developmental milestones required for a production-quality prototype of the company’s nanoparticle-based green hydrogen technology by the end of Q4 2022. These targets included:

    Successful fabrication of semiconductor units at production-quality prototype scales

    Successful integration of membranes at production-quality prototype scales

    Successful integration of catalysts at production-quality prototype scales

    Successful testing and demonstration of production-quality prototype units

    SunHydrogen is pleased to share that it remains on track to demonstrate a production-quality prototype of its nanoparticle-based green hydrogen technology by the end of Q4 2022.

    “Our foremost achievement this quarter was the successful fabrication of one of our two proprietary semiconductor units at production-quality prototype scale,” said Chief Scientific Officer Dr. Syed Mubeen. “We have thoroughly tested its ability for hydrogen production using sunlight and water containing organics derived from biomass resources.”

    The company is still working to resolve the supply chain challenges that have delayed fabrication of its second proprietary semiconductor unit. However, its scientific team has identified an alternate strategy utilizing commercially available silicon solar cells with heterojunction technology, and initial attempts have shown promise.

    SunHydrogen has also made progress on membrane integration and is currently working with two industrial partners, Ionomr Innovations and Chromis Technologies, to integrate both proton exchange membranes (PEM) and anion exchange membranes (AEM) into its proprietary substrates and evaluate performance metrics for sustainable hydrogen production.

    Based in Vancouver, Canada, Ionomr Innovations develops advanced ion-exchange membranes and polymers, enabling product developers and integrators to optimize their product performance, improve durability, eliminate toxic components, increase recyclability and accelerate down the cost curve earlier than expected.

    New Jersey-based Chromis Technologies manufactures custom amorphous fluoropolymers to deliver optimal performance for myriad high-value specialty applications and has a proven track record of success and innovation spanning over two decades.

    Additionally, SunHydrogen is working with new industrial partners Optimum Anode of California and RuC2N of South Korea, as well as with existing partner the University of Michigan, to achieve successful catalyst integration and identify the best catalyst for hydrogen and oxygen production.

    Lastly, SunHydrogen continues to work with SCHMID Group of Germany to design and engineer its panel housing, a critical system element that ensures safe and efficient hydrogen collection. The company’s nanoparticle-based hydrogen generators, integrated with membrane and catalyst, will be housed in production-quality prototype units for hydrogen demonstration purposes.

    “As we head into Q3 and Q4 2022, we are making steady progress toward the goals we have set for the remainder of the year,” said SunHydrogen CEO Tim Young. “We have a dedicated team and a growing number of respected industrial partners, and we will continue doing our best to push past any supply chain challenges and setbacks that come our way.”
  13. Radikal 28 juni 2022 15:43
    quote:

    nine_inch_nerd schreef op 28 juni 2022 15:41:

    Beweging en voortgang, maar niet ets concreets. Al maanden hetzelfde verhaal.
    Daarvoor zullen we moeten tot Q4 hé.
    In ieder geval goed dat de milestones gerespecteerd blijven.
  14. Radikal 28 juni 2022 16:14
    Als, ik zeg duidelijk ALS, ze kunnen waarmaken wat ze beloven, ahwel dan hebben we een gouden parel in handen.
  15. Radikal 19 juli 2022 13:09
    SunHydrogen Well-Capitalized for Nanoparticle-Based Green Hydrogen Technology’s Continued Development Toward Commercialization

    Company will also begin pursuing strategic investments in complementary technologies

    SANTA BARBARA, CA – July 19, 2022 – SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today shared an update detailing the Company’s financial position following the completion of the 2022 fiscal year on June 30.

    SunHydrogen reports a financial position of $52 million in cash and cash equivalents on its balance sheet as of June 30, 2022, a number that instills confidence in its executive and scientific teams alike as the Company continues moving toward the commercialization of its nanoparticle-based green hydrogen technology.

    SunHydrogen is currently at a critical developmental juncture with the goal of a production-quality prototype set for the end of 2022.

    “Being well-capitalized at this time not only allows us to feel confident about seeing our technology through to commercial viability, but it also allows us to begin exploring strategic investments in the hydrogen space,” said SunHydrogen’s CEO Tim Young.

    “SunHydrogen is actively pursuing opportunities for investment and acquisition of complementary hydrogen technologies,” Mr. Young continued. “Amid the widespread market downturn, we are fortunate to have the resources to fully support our own technology and simultaneously maximize our impact in this fast-growing industry.”

    The Company’s investment strategy will be led by Chief Operating Officer Woosuk Kim, who formerly served as Senior Vice President and Head of the M&A Group at Seoul-based SK Innovation. Mr. Kim has executed over $4 billion in mergers, acquisitions and joint ventures throughout his career.

    SunHydrogen’s full annual report will be available in accordance with SEC regulations in September 2022.
  16. forum rang 9 nine_inch_nerd 19 juli 2022 14:45
    quote:

    nine_inch_nerd schreef op 28 juni 2022 15:41:

    Beweging en voortgang, maar niet iets concreets.
    Hou vol en ik kijk toe.
    OTC markt zal voor mij niet meer mogelijk zijn nu ik bij Binck/Saxo weg ben.
    Dus wachten op een reverse-split en intrede op Nasdaq. Als het zo ver komt.
  17. Radikal 19 juli 2022 15:14
    quote:

    nine_inch_nerd schreef op 19 juli 2022 14:45:

    [...]

    Hou vol en ik kijk toe.
    OTC markt zal voor mij niet meer mogelijk zijn nu ik bij Binck/Saxo weg ben.
    Dus wachten op een reverse-split en intrede op Nasdaq. Als het zo ver komt.
    Ik heb ze ook al lange tijd en hoop de komende jaren er de vruchten van te plukken.
    Afwachten dus.
461 Posts
Pagina: «« 1 ... 18 19 20 21 22 ... 24 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.930
AB InBev 2 5.394
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.581 50.015
ABO-Group 1 21
Acacia Pharma 9 24.692
Accell Group 151 4.131
Accentis 2 262
Accsys Technologies 22 9.864
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 175
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 13 17.443
Aedifica 3 890
Aegon 3.257 321.809
AFC Ajax 537 7.062
Affimed NV 2 6.111
ageas 5.843 109.854
Agfa-Gevaert 13 1.970
Ahold 3.536 74.174
Air France - KLM 1.024 34.753
AIRBUS 1 10
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.947
Alfen 15 22.729
Allfunds Group 3 1.397
Almunda Professionals (vh Novisource) 651 4.250
Alpha Pro Tech 1 17
Alphabet Inc. 1 384
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.800
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.826 241.395
AMG 967 131.310
AMS 3 73
Amsterdam Commodities 303 6.633
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 419
Antonov 22.632 153.605
Aperam 91 14.616
Apollo Alternative Assets 1 17
Apple 5 358
Arcadis 251 8.682
Arcelor Mittal 2.029 319.964
Archos 1 1
Arcona Property Fund 1 285
arGEN-X 15 9.897
Aroundtown SA 1 215
Arrowhead Research 5 9.552
Ascencio 1 25
ASIT biotech 2 697
ASMI 4.107 38.703
ASML 1.764 94.992
ASR Nederland 19 4.402
ATAI Life Sciences 1 7
Atenor Group 1 386
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 31 12.823
Axsome Therapeutics 1 177
Azelis Group 1 62
Azerion 7 2.939

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 31 oktober

    1. Holland Colours halfjaarcijfers
    2. Inkoopmanagersindices industrie en diensten oktober (Chi)
    3. Bank of Japan rentebesluit 0,25% (onveranderd) volitaliteit verwacht
    4. Inflatie oktober vlpg (NL)
    5. Arcadis Q3-cijfers
    6. DSM-Firmenich Q3-cijfers
    7. Flow Traders Q3-cijfers
    8. Heijmans Q3-cijfers
    9. ING Q3-cijfers
    10. Van Lanschot Kempen Q3-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht